MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY

Location

Founded

1989-12-19

Risk Signals

4960 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY

Live alerts from global media, monitored by Business Radar

These 10 medtech companies care a lot about RD

2023-12-29 (medicaldesignandoutsourcing.com)

These 10 medtech companies care a lot about RD

Of the 100 largest medical device companies, these 10 firms have spent the largest portion of their revenues on research and development.

Read more
FTC Takes a Stand: Challenging Antitrust Practices in the Medical Device Industry - MyChesCo

2023-07-09 (mychesco.com)

FTC Takes a Stand: Challenging Antitrust Practices in the Medical Device Industry - MyChesCo

The Federal Trade Commission recently filed a friend-of-the-court (amicus) brief in the U.S. District Court for the Central District of California, clarifying legal standards that apply in antitrust cases involving exclusive-dealing and ...

Read more
FTC critiques Medtronic's legal reasoning in antitrust case

2023-07-05 (massdevice.com)

FTC critiques Medtronic's legal reasoning in antitrust case

The U.S. Federal Trade Commission wants to have a say in Applied Medical Resources' antitrust lawsuit against Medtronic.

Read more
FTC Submits Amicus Brief On Antitrust Standards Regarding Bundling Arrangements

2023-07-04 (competitionpolicyinternational.com)

FTC Submits Amicus Brief On Antitrust Standards Regarding Bundling Arrangements

The Federal Trade Commission submitted a friend-of-the-court brief in the U.S. District Court for the Central District of California...

Read more
Device maker Medtronic blasts rival's 'threadbare' antitrust lawsuit

2023-04-26 (indiatimes.com)

Device maker Medtronic blasts rival's 'threadbare' antitrust lawsuit

Medical Technology Company: Medtronic, the world 's largest standalone medical device maker, said Applied Medical mustered `` weak '' arguments that Medtronic 's discount program for hospitals- providing them lower prices for using more than one of the company 's products- violated US antitrust

Read more
Device maker Medtronic blasts rival's 'threadbare' antitrust lawsuit | Pictures | Reuters

2023-04-25 (reuters.com)

Device maker Medtronic blasts rival's 'threadbare' antitrust lawsuit | Pictures | Reuters

FILE PHOTO: Medtronic Plc logo is seen displayed in this illustration taken, April 10, 2023. REUTERS/Dado Ruvic/Illustration

Read more
Device maker Medtronic blasts rival’s ‘threadbare’ antitrust lawsuit

2023-04-25 (wkzo.com)

Device maker Medtronic blasts rival’s ‘threadbare’ antitrust lawsuit

By Mike Scarcella (Reuters) - Medical technology company Medtronic PLC has asked a U.S. judge in California to dismiss as "threadbare" an antitrust la...

Read more
US Medical Device Maker Medtronic Faces New Antitrust Suit

2023-02-16 (competitionpolicyinternational.com)

US Medical Device Maker Medtronic Faces New Antitrust Suit

A US medical resource group has recently accused Medtronic of using its size to shut down competition in the market for...

Read more
Medtronic caught up in DOJ ventilator antitrust probe dating back to Covidien deal: WSJ

2020-10-02 (fiercebiotech.com)

Medtronic caught up in DOJ ventilator antitrust probe dating back to Covidien deal: WSJ

The Department of Justice has begun investigating whether Medtronic’ s acquisitions curbed competition among manufacturers of ventilators—and potentially| The Department of Justice has begun investigating whether Medtronic’ s acquisitions curbed competition among manufacturers of ventilators

Read more
AbbVie gains U.S. nod for $63B Allergan takeover

2020-05-06 (massdevice.com)

AbbVie gains U.S. nod for $63B Allergan takeover

Pharmaceutical giant AbbVie (NYSE:ABBV) has won U.S. antitrust approval for its purchase of Allergan (NYSE:AGN) for $63 billion in cash and stock. The purchase is seen as a hedge against the impending expiration of U.S. patents on AbbVie’s blockbuster drug, Humira.

Read more
Bill Hawkins on his time at Medtronic, Immucor and 25 years in the hot seat | DeviceTalks podcast

2016-03-08 (massdevice.com)

Bill Hawkins on his time at Medtronic, Immucor and 25 years in the hot seat | DeviceTalks podcast

For nearly a quarter of a century, William “Bill” Hawkins sat in the corner office of medtech companies of all sizes, before stepping down from Immucor last year to become the Atlanta-based company’s lead director.

Read more
Medtronic Gets U.S. Antitrust OK to Buy Covidien with Divestiture

2015-03-24 (foxbusiness.com)

Medtronic Gets U.S. Antitrust OK to Buy Covidien with Divestiture

Closed Captioning Policy Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset . Powered and implemented by FactSet Digital Solutions . Legal Statement . Mutual Fund and ETF data provided by Refinitiv Lipper

Read more

Never miss a headline about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages